Lilly is a medicine company making life better for people around the world. We've turned science into pioneering new discoveries for nearly 150 years, and today, our medicines support more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges; redefining diabetes care; treating obesity; advancing the fight against Alzheimer's disease; providing options for some of the most debilitating immune system disorders; and targeting the most difficult-to-treat cancers.
 
For over 35 years, Lilly has driven scientific progress in Alzheimer’s disease to improve diagnostics, treatments, and outcomes for patients. It’s our vision that, in 10 years, timely detection, accurate diagnosis, appropriate treatment and ultimately prevention, will be a reality for people with Alzheimer’s disease. With each step towards a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more visit Lilly.com.au or follow us on LinkedIn.